Clinical pharmacokinetics of mycophenolic acid: a comparison between the two formulations of mycophenolate mofetil (Cellcept and Myfenax) and the enteric-coated mycophenolate sodium (Myfortic) in adult renal transplant recipients in the early transplant period

Pilar Salvador-Garrido

[P26-6-5] Clinical pharmacokinetics of mycophenolic acid: a comparison between the two formulations of mycophenolate mofetil (Cellcept and Myfenax) and the enteric-coated mycophenolate sodium (Myfortic) in adult renal transplant recipients in the early transplant period

Pilar Salvador-Garrido¹, Maria Outeda-Macias², Constantino Fernandez-Rivera³, Angel Alonso-Hernandez⁴, Isaura Pedreira-Vazquez⁵, Isabel Martin-Herranz⁶ (1.A Coruna University Hospital Complex, 2.A Coruna University Hospital Complex, 3.A Coruna University Hospital Complex, 4.A Coruna University Hospital Complex, 5.A Coruna University Hospital Complex, 6.A Coruna University Hospital Complex)

Keywords:Cellcept, Myfenax, Myforti, AUC0-12

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

Presentation information

[P26-6] P26-6: Immunosuppressive drugs (5): Clinical practice

[P26-6-5] Clinical pharmacokinetics of mycophenolic acid: a comparison between the two formulations of mycophenolate mofetil (Cellcept and Myfenax) and the enteric-coated mycophenolate sodium (Myfortic) in adult renal transplant recipients in the early transplant period

Password